This is the latest T20 I could find (Iress Viewpoint): As at 28 Feb 2018: Many of the holders unchanged since pre-NST buying stake (2017 Annual Report release on 2 Oct 2017).
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025